Etiopathogenetic therapy of acute viral etiology in children

Etiopathogenetic therapy of acute viral etiology in children
Among all infectious diseases, acute intestinal infections (AII) are the most common. Children of early and preschool age are particularly susceptible to intestinal infections of viral etiology.
Author: A.A. Novokshonov, MD, PhD, Professor, Russian State Medical University, Moscow
Keywords: #acute_intestinal_infections, #diarrhea, #rotavirus, #gastroenteritis, #rehydration, #sorbents, #probiotics, #immunomodulators, #therapeutic_nutrition
In 1972, the Norwalk virus (norovirus) was discovered in Ohio, USA, as a causative agent of gastroenteritis in children. The role of rotavirus as an etiological factor of diarrhea was first established in animals in the 1950s. In 1973, rotavirus was detected in the coprofiltrate of children with gastroenteritis, and its role as an etiological factor was proven. In subsequent years, the etiological structure of viral diarrheas expanded significantly. It was established that human viral diarrheas can be caused by infectious agents such as astroviruses, sapoviruses, coronaviruses, toroviruses, adenoviruses (serotypes 31, 40, 41), Coxsackie A enteroviruses (serotypes 18, 20, 21, 22, 24), ECHO- and reoviruses, as well as influenza A virus (H5N1), bocaviruses, and others [1—5].

Causes of the Disease

According to international statistics, viral diarrheas account for 50—80% of the overall structure of acute intestinal infections (AII). Rotaviruses and noroviruses hold the leading place in the etiology of viral diarrheas. In Russia, the proportion of viral diarrheas in the overall structure of AII incidence in children ranges from 18—24% in the summer to 70—78% in the autumn-winter-spring period.

Rotaviruses are the cause of more than 125 million cases of childhood gastroenteritis and approximately 440,000 fatal outcomes annually. In the United States, up to 23 million cases of diseases caused by noroviruses are registered annually, with up to 300 fatal cases among them [6, 7, 8]. In Russia, the proportion of viral diarrheas in the overall structure of AII incidence in children ranges from 18—24% in the summer to 70—78% in the autumn-winter-spring period. In Moscow, group A rotaviruses (54.3%), noroviruses of the 2nd genotype (25.2%), and adenoviruses (13.2%) are the most common, while astroviruses (4.5%) are less frequent, and group C rotaviruses, noroviruses of the 1st genotype, and sapoviruses account for 1—1.2% of cases each [9—11].

Regardless of the etiological factor, viral enteritis and gastroenteritis proceed as osmotic-type diarrhea. The "trigger" mechanism of diarrhea and the infectious process is based on disaccharidase (primarily lactase) deficiency, which develops as a result of virus replication in the epithelial cells of the small intestine. As a result of enzymopathy, undigested carbohydrates (disaccharides) are not absorbed, accumulate in the intestinal lumen, and, having high osmotic activity, prevent water absorption from the intestine. Under the influence of microflora, disaccharides undergo fermentation, accompanied by the formation of a large amount of gas (fermentative dyspepsia - flatulence). Increased gas formation contributes to the appearance of pain syndrome and accelerated intestinal peristalsis - "watery" diarrhea. The severity and outcome of the disease depend on the presence and severity of toxemia and exsicosis (dehydration) (Fig. 1).

The diseases have a pronounced seasonal character (autumn-winter period), and predominantly affect young children. An acute onset is characteristic, with an increase in body temperature (up to 38—39°C) and repeated vomiting. Simultaneously or after a few hours, loose, copious, watery stools of yellow or yellow-green color appear, undigested, often foamy or explosive, up to 10—15 or more times a day. Abdominal pain is mainly associated with increased gas formation, has a cramping character, and is usually accompanied by rumbling in the abdomen. Pathological impurities in the stool (mucus, greens, blood) are absent, and the stools often have a sharp, sour smell.

Viral gastroenteritis is most often recorded in children aged 6 months to 3 years. It is at this age that the risk of infection and severe disease course with the development of severe dehydration and possible fatal outcome is highest.

Recently, along with the study of the etiological structure, features of clinical manifestations, and pathogenesis of viral diarrheas (Fig. 1), issues of strategy and tactics for complex therapy are being studied. Etiopathogenetic therapy is built mainly based on pathophysiological concepts of the mechanism of diarrhea and infectious process development (Fig. 2).

Этиопатогенетическая терапия оки вирусной этиологии у детей


The full text of the article is available in the file "Etiopathogenetic Therapy of Viral Acute Intestinal Infections in Children."


Our Products:

Over-the-Counter (OTC):

Lactofiltrum® 325 mg + 120 mg , Filtrum® 400 mg , Micrasim® 25,000 IU , Micrasim® 10,000 IU , Micrasim® 40,000 IU , Ecofuril® capsules 100 mg Ecofuril® capsules 200 mg , Ecofuril® oral suspension 90 ml , Ecofucin® vaginal suppositories 100 mg , Ecobiotic Immuno , Lactofiltrum® Skin detox , Heli-Stop® tablets 120 mg , Vikalin tablets , Potassium Orotate tablets 500 mg , Lactulose syrup , Pancreatin tablets 100 mg , Simeotic® 40 mg , Simeotic® 80 mg

Prescription-Only:

Minolexin® capsules 50 mg , Minolexin® capsules 100 mg , Azithromycin Ecomed® tablets 250 mg , Azithromycin Ecomed® powder for oral suspension 100 mg/5 ml vial , Azithromycin Ecomed® powder for oral suspension 200 mg/5 ml vial , Azithromycin Ecomed® tablets 500 mg , Amoxicillin Ecobol® tablets 250 mg , Amoxicillin Ecobol® tablets 500 mg , Ecoclav® (Amoxicillin + Clavulanic Acid) powder for oral suspension 125 mg+31.25 mg/5 ml , Ecoclav® (Amoxicillin + Clavulanic Acid) powder for oral suspension 250 mg+62.5 mg/5 ml , Ecoclav® (Amoxicillin + Clavulanic Acid) tablets 250 mg+125 mg , Ecoclav® (Amoxicillin + Clavulanic Acid) tablets 500 mg+125 mg , Ecoclav® (Amoxicillin + Clavulanic Acid) tablets 875 mg+125 mg , Ciprofloxacin Ecocifol® tablets 500 mg , Ciprofloxacin Ecocifol® tablets 250 mg , Clarithromycin Ecozitrin® tablets 250 mg , Clarithromycin Ecozitrin® tablets 500 mg , Levofloxacin Ecolevid® tablets 500 mg , Levofloxacin Ecolevid® tablets 250 mg , Levofloxacin Ecolevid® tablets 250 mg , Gelmindazole tablets 100 mg , Itraconazole capsules 100 mg , Motonium® tablets 10 mg , Nimesulide tablets 100 mg , Nimesulide® granules for oral suspension , Ursoliv® capsules 250 mg , Amoxicillin tablets 250 mg , Amoxicillin tablets 500 mg , Amiodarone tablets 200 mg , Verapamil tablets 80 mg , Diazolin 50 mg , Diazolin 100 mg , Indapamide tablets 2.5 mg , Captopril-STI tablets 50 mg , Methionine tablets 250 mg , Nicergoline tablets 10 mg , Omeprazole capsules 20 mg , Simvastatin tablets 20 mg , Simvastatin tablets 10 mg , Simvastatin tablets 40 mg , Erythromycin tablets 250 mg